+44 (0)1865 595230
0 Items

Oropouche Virus

Oropouche virus (OROV) is one of the most common arboviruses that infects humans in Brazil. It is estimated that since the virus was first isolated in 1955, it has infected more than half a million people. However, it is often mistakenly diagnosed as Dengue, Zika or Chikungunya virus, and therefore true levels of infection are unclear.

The Native Antigen Company offers a range of Oropouche antigens to support the development of assays to reliably detect infection.

Oropouche Virus Background

Oropouche virus (OROV) is an RNA virus, belonging to the family Bunyaviridae. Phylogenetic analysis of OROV has identified 4 virus genotypes (I, II, III, IV), which all occur in Brazil. In humans, OROV causes Oropouche fever, which is clinically characterised by a rapid-onset acute febrile illness. Oropouche fever is reported to be the second most common arboviral disease, next to Dengue fever, in the Brazilian Amazon region. Other symptoms associated with the disease are like those reported for Dengue, Zika, chikungunya, yellow fever and include headache, myalgia, joint pain, nausea and vomiting. In some cases, OROV can cause a form of viral meningitis.

In humans, OROV is transmitted by the biting midge, culicoides paraensis, an insect vector that lives in urban areas and is widely distributed in South America. Since the virus was first isolated in 1955, OROV has caused 30 large-scale epidemics in the Amazon region, infecting at least 500,000 people. The incidence of Oropouche fever has now become widespread in Latin American countries where c. paraensis is present.

Considering the geographical spread of OROV and the similarity of symptoms between Oropouche and fever infections caused by Dengue, Zika, Chikungunya and Yellow Fever viruses, it is important to reliably differentiate between these arboviral diseases with accurate diagnostics.

References

  1. World Health Organization (WHO). Oropouche Virus disease – Peru. http://www.who.int/csr/don/03-june-2016-oropouche-peru/en/
  2. Vasconcelos, H.B. et al (2011). Molecular epidemiology of Oropouche virus, Brazil. Emerg Infect Dis. 17:800-6
  3. Sakkas, H. et al (2018) Oropouche Fever: A Review Viruses 10:175

Oropouche Antigens

In support of Oropouche infection research, we offer a range of antigens relevant to immunoassay and vaccine research. These include OROV Gc and Gn glycoprotiens, expressed in our mammalian cell system and the non-glycosylated nucleoprotein, expressed in E. coli.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Challenges to Effective Yellow Fever Diagnostics

Yellow fever is a haemorrhagic viral disease, transmitted by infected mosquitos in Africa and South America. While an effective vaccine is available, inadequate vaccination of endemic areas has made diagnostics a necessity to controlling ongoing outbreaks. However,...

Five Methods You Can Use to Overcome Zika-Dengue Cross-Reactivity

Cross-reactivity between the Zika and Dengue viruses in serological assays is one of the biggest challenges faced by the epidemiologists, academics and pharmaceutical companies trying to control the Zika epidemic, as it brings the quality and reliability of diagnostic...

Why Zika virus’s cross-reactivity with Dengue might be hampering your research

Given the impact of Zika, it’s no surprise that a global contingent of epidemiologists, academic researchers, and pharmaceutical companies are striving to develop effective disease control measures and treatments. One challenge currently hindering the...

How The Native Antigen Company responds to the WHO list of priority infectious diseases

In 2015, a broad group of public health and science experts gathered in Geneva to discuss emerging infectious diseases that are likely to cause future severe epidemics and public health emergencies. Organised by the World Health Organization (WHO), their aim was to...

Native Antigen release a panel of serotype specific monoclonal antibodies

  There are four distinct serotypes of Dengue Virus circulating around the world, causing Dengue fever infection which is the most important worldwide arboviral disease. There are nearly 400 million cases of Dengue annually, and around 25% present with so called...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

6 + 7 =

Live Customer Feedback